Coeptis Therapeutics Holdings, Inc. Warrants (COEPW) Stock Price
COEPWStock
$0.00
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta-0.17
COEPW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-72.44%
Price vs S&P 500 (4W)-28.04%
VGM Score34.20
Industry Peers — Finance Services(167)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
COEPWCoeptis Therapeutics Holdings, Inc. Warrants | — | — | D | $0.00 |
| AXPAmerican Express Company | D | B | B | $335.95 |
| NUNu Holdings Ltd. | D | B | B | $15.14 |
| MSTRStrategy Inc Common Stock Class A | D | D | C | $126.83 |
| COINCoinbase Global, Inc. Class A Common Stock | D | C | C | $187.16 |
| SYFSYNCHRONY FINANCIAL | B | C | B | $80.77 |
| CRCLCircle Internet Group, Inc. | D | C | C | $92.02 |
| SOFISoFi Technologies, Inc. Common Stock | D | B | B | $19.00 |
| IRENIREN Limited Ordinary Shares | F | B | C | $42.21 |
| BMNRBitMine Immersion Technologies, Inc. | D | A | B | $24.82 |
| CHYMChime Financial, Inc. Class A Common Stock | D | B | A | $33.10 |
About Coeptis Therapeutics Holdings, Inc. Warrants
Coeptis Therapeutics is a biopharmaceutical company developing cell therapies for CD38-related cancers. The company's pipeline includes multi-antigen CAR T technology (SNAP-CAR) licensed from the University of Pittsburgh, a CD38-targeting natural killer cell therapy (CD38-GEAR-NK), and companion diagnostics developed with VyGen-Bio and the Karolinska Institutet.